Eads & Heald Wealth Management Buys 50 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Eads & Heald Wealth Management increased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 14.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 400 shares of the medical instruments supplier’s stock after purchasing an additional 50 shares during the quarter. Eads & Heald Wealth Management’s holdings in Mettler-Toledo International were worth $489,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MTD. Benjamin F. Edwards & Company Inc. boosted its stake in shares of Mettler-Toledo International by 12.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 131 shares of the medical instruments supplier’s stock worth $183,000 after buying an additional 15 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in Mettler-Toledo International by 52.5% in the second quarter. Pacer Advisors Inc. now owns 3,853 shares of the medical instruments supplier’s stock valued at $5,385,000 after acquiring an additional 1,327 shares during the period. ProShare Advisors LLC boosted its position in Mettler-Toledo International by 6.6% in the second quarter. ProShare Advisors LLC now owns 3,098 shares of the medical instruments supplier’s stock worth $4,330,000 after purchasing an additional 193 shares during the last quarter. Frank Rimerman Advisors LLC grew its stake in shares of Mettler-Toledo International by 12,700.0% during the 2nd quarter. Frank Rimerman Advisors LLC now owns 384 shares of the medical instruments supplier’s stock valued at $537,000 after purchasing an additional 381 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Mettler-Toledo International by 11.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 106 shares of the medical instruments supplier’s stock worth $161,000 after purchasing an additional 11 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on MTD shares. Stifel Nicolaus cut their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company cut their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus price target of $1,351.25.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Up 2.3 %

Shares of MTD opened at $1,325.38 on Wednesday. The business’s 50 day moving average is $1,242.44 and its 200 day moving average is $1,343.58. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The company has a market capitalization of $27.97 billion, a PE ratio of 35.73, a price-to-earnings-growth ratio of 4.10 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.